These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1975961)

  • 21. [Alzheimer's disease and neurotransmitters].
    Nakamura S
    Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):30-40. PubMed ID: 1672465
    [No Abstract]   [Full Text] [Related]  

  • 22. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
    Perry RH; Perry EK; Smith CJ; Xuereb JH; Irving D; Whitford CA; Candy JM; Cross AJ
    J Neural Transm Suppl; 1987; 24():131-6. PubMed ID: 2824687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aging of memory mechanisms].
    Lamour Y; Bassant MH; Potier B; Billard JM; Dutar P
    C R Seances Soc Biol Fil; 1994; 188(5-6):469-86. PubMed ID: 7780790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
    De Souza EB; Whitehouse PJ; Kuhar MJ; Price DL; Vale WW
    Nature; 1986 Feb 13-19; 319(6054):593-5. PubMed ID: 3003585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotransmitters and neuropeptides in Alzheimer's disease.
    McDonald WM; Nemeroff CB
    Psychiatr Clin North Am; 1991 Jun; 14(2):421-42. PubMed ID: 1676509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical models for cognition enhancers.
    Costall B; Barnes JM; Hamon M; Müller WE; Briley M
    Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():85-8; discussion 89. PubMed ID: 2186420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease: cognitive and behavioral pharmacotherapy.
    Cummings JL; Mendez MF
    Conn Med; 1997 Sep; 61(9):543-52. PubMed ID: 9334509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations.
    Mazurek MF; Beal MF; Bird ED; Martin JB
    Ann Neurol; 1986 Dec; 20(6):665-70. PubMed ID: 3813496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuro-modulation, aminergic neuro-disinhibition and neuro-degeneration. Draft of a comprehensive theory for Alzheimer disease.
    Schmitt HP
    Med Hypotheses; 2005; 65(6):1106-19. PubMed ID: 16125326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone.
    Hyman BT; Van Hoesen GW; Damasio AR
    Ann Neurol; 1987 Jul; 22(1):37-40. PubMed ID: 2443073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Senile dementia of the Alzheimer type.
    Terry RD; Katzman R
    Ann Neurol; 1983 Nov; 14(5):497-506. PubMed ID: 6139975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological basis of drug therapy of Alzheimer's disease.
    Sharma A; Parikh V; Singh M
    Indian J Exp Biol; 1997 Nov; 35(11):1146-55. PubMed ID: 9567741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical substrates in normal aging and Alzheimer's disease.
    Wallin A; Gottfries CG
    Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():37-43. PubMed ID: 1970889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug therapy of Alzheimer's disease. Problems and strategy in development of new therapeutic drugs for Alzheimer's disease].
    Moroji T; Matsuzaki I
    Nihon Rinsho; 1988 Jul; 46(7):1586-91. PubMed ID: 2906096
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug therapy of Alzheimer's disease using neurotransmitter-related substances].
    Nakamura S
    Nihon Rinsho; 1988 Jul; 46(7):1580-5. PubMed ID: 2906095
    [No Abstract]   [Full Text] [Related]  

  • 36. The interplay of neurotransmitters in Alzheimer's disease.
    Francis PT
    CNS Spectr; 2005 Nov; 10(11 Suppl 18):6-9. PubMed ID: 16273023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease.
    Gottfries CG
    Gerontology; 1986; 32 Suppl 1():98-101. PubMed ID: 2874102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of Tiaoxin and Zishen prescription on hippocampus neurotransmitters in Alzheimer's disease rats].
    Bao XQ; Liu B; Sun B
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Feb; 21(1):55-7. PubMed ID: 21166165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotransmitters and second messengers in aging and Alzheimer's disease.
    Francis PT; Webster MT; Chessell IP; Holmes C; Stratmann GC; Procter AW; Cross AJ; Green AR; Bowen DM
    Ann N Y Acad Sci; 1993 Sep; 695():19-26. PubMed ID: 7902054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuropeptides and Alzheimer's disease].
    Jiménez A; Astarloa R; Morales B
    Neurologia; 1991 Jan; 6(1):17-24. PubMed ID: 1677810
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.